Pitch & Partner

A platform for orphan drug biotechs to meet and present their development programs to investors

30+ biotech startups will be selected to present their programs and companies at Pitch & Partner. 

 

The track will also feature discussions by VCs investors, successfully funded biotechs and grant agencies to educate the industry about challenges and opportunities of the orphan drugs market investment landscape.

 

Interested in presenting? Contact Andre now at +1 646 619 1797 or andre.singer@terrapinn.com

 

 

DOWNLOAD PITCH & PARTNER APPLICATION FORM

 

Who should apply?

 

  • Biotechs in the US, Europe, Japan, Canada or abroad which have been granted orphan drug designation within their regulatory constituencies
  • Any stage of development – from pre-clinical to late stage development whose current objectives include raising capital from VCs, grants and awards or looking for co-development, partnership, licensing and/or M&A opportunities

 

How to apply:

 

  • Fill out the application form contained in the Pitch & Partner Prospectus
  • Submit the complete application form it by e-mail to Terrapinn before September 29th – incomplete forms will be immediately disregarded
  • If your company meets the abovementioned criteria, Terrapinn will be in touch with you to collect additional information about your organization and orphan drugs progra
  • Once officially confirmed, applicants will be requested to fill out a company profile form and submit the outline of your presentation

 

WHO IS IN THE AUDIENCE:
 


 

  • Venture Capital firms
  • Orphan drugs biotechs represented by their CEOs, VPs of Business Development and VPs of R&D
  • Big pharma and commercial-stage biotechs represented by VPs of External R&D/Innovation, Chief R&D Officers,
  • Chief Scientific Officers and Chief Medical Officers
  • Public and private grant agencies
  • Research Foundations and Patient Groups looking to allocate funds into research in their respective disease areas
  • Investment banks

HOW THE PRESENTATION & PROGRAM WORKS:
 


 

 

1)  Once your organization is confirmed to present- upon submission of the company profile sheet, you will recieve one complementary pass for your representative to attend the entire conference on April 10-12, 2019 (Savings of up to $2500)
  • The company profile sheet includes information about your proposed session outline, including the topic of the presentation
  • Presenters will be granted access to all conference activities, features and presentations on April 10-12
2) By October 31st, your company will be designated a specific time slot on April 11 or April 12 for your 10 minute presentation
  • Presentations will be held on the Pitch & Partner track of the conference
3) Presentors are allowed to use up to 5 slides in their presentation, which need to be submitted for review & testing by April 1, 2019